Abterra Biosciences

About:

Abterra Biosciences uses technology to map the antibody response, and rapidly identify better therapeutic antibodies.

Website: https://abterrabio.com

Twitter/X: abterrabio

Top Investors: National Institutes of Health, Small Business Innovation Research

Description:

Abterra Biosciences provides technologies that use the latest in next-generation sequencing, mass spectrometry, and machine learning methods to comprehensively map the antibody response, and rapidly identify better therapeutic antibodies. Abterra Biosciences assembles an interdisciplinary team of data scientists and biologists to reimagine the development of antibody therapeutics. Alicanto, a novel antibody discovery platform developed by Abterra Biosciences, identifies target-specific antibodies in serum. It identifies high-affinity antibodies without the need for time-consuming and inefficient cell selection, fusions, or cloning.